Related Experiment Video

Updated: Jun 27, 2026

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

A suppressor of multiple extracellular matrix-degrading proteases and cancer metastasis

Lan Lan Yin1, Chin Man Chung, Jie Chen

  • 1Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.

Journal of Cellular and Molecular Medicine
|November 20, 2008
PubMed

Insights

A newly discovered protein, NYD-SP8, suppresses cancer metastasis by inhibiting key proteases involved in extracellular matrix degradation. This finding offers a novel therapeutic target for reducing cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer metastasis is a complex process driven by extracellular matrix (ECM) degradation.
  • Tumor-associated proteases play a critical role in facilitating cancer cell invasion and spread.

Purpose of the Study:

  • To identify and characterize novel regulators of cancer metastasis.
  • To investigate the role of the newly identified protease suppressor, NYD-SP8, in cancer progression.

Main Methods:

  • Identification of NYD-SP8 located on human chromosome 19q13.2.
  • Co-immunoprecipitation to analyze the interaction of NYD-SP8 with urokinase plasminogen activator (uPA) and its receptor (uPAR).
  • Assessment of protease activity (uPA, MMPs, cathepsin B) and cancer cell invasion assays in vitro and in vivo.

Main Results:

  • NYD-SP8 encodes a GPI-anchored cell surface protein homologous to uPAR.
  • NYD-SP8 binds to uPA/uPAR complexes, inhibiting active uPA production.
  • Overexpression of NYD-SP8 significantly reduced ECM-degrading protease activities and suppressed cancer cell invasion and metastasis.

Conclusions:

  • NYD-SP8 acts as a novel protease suppressor, regulating ECM degradation.
  • NYD-SP8 modulates urokinase signaling, offering a new mechanism for suppressing cancer progression.
  • NYD-SP8 represents a potential therapeutic target for inhibiting cancer metastasis.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix01:42

The Extracellular Matrix

In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.Composition of the Extracellular MatrixThe extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse molecules.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...